Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchlosartannanoparticlesnecroptosispreclinical

Losartan nanoparticles studied in rat model of cerebellar injury

Molecular Neurobiology paper links treatment to changes in RIPK1/RIPK3/MLKL necroptosis markers after carbon tetrachloride exposure.

PR
By Priya Raman · Science Reporter
Sep 16 20:00 ETSource: Molecular neurobiology

The wire

  1. 01Researchers tested losartan nanoparticles in rats with carbon tetrachloride-induced cerebellar injury.
  2. 02The work probes necroptosis pathways as targets in neural injury.
  3. 03Preclinical findings in rodents require confirmation before any clinical relevance.

From the source

Impact of Losartan Nanoparticles on Carbon Tetrachloride-induced Cerebellar Injury in Rats: Association with Alterations in RIPK1/RIPK3/MLKL Necroptosis Markers

Molecular neurobiology · 2026 Sep 17 · Lashine NH, Elhessy HM, Hammad MO et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42749941/